NAGE FY 2015 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$392M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M+16.8% YoY

Gross Profit

$8M42.1% margin

Operating Income

-$2M-11.6% margin

Net Income

-$3M-15.5% margin

EPS (Diluted)

$-0.08

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$19M

Total Liabilities

$13M

Stockholders' Equity

$5M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$15M	+16.8%
Gross Profit	$8M	$5M	+41.5%
Operating Income	-$2M	-$5M	+60.5%
Net Income	-$3M	-$5M	+48.6%